Learn More
Apexbio Technology LLC ACPT-I 194918-76-8 10mg

Supplier: Apexbio Technology LLC B505110
ACPT-I (CAS 194918-76-8) is a small molecule agonist that selectively targets group III metabotropic glutamate receptors (mGluRs) By modulating glutamatergic neurotransmission ACPT-I has been shown in preclinical studies to confer neuroprotection reduce central nervous system excitability and exhibit anticonvulsant as well as anxiolytic properties These pharmacological effects support its use in research on neurodegenerative disorders and epilepsy where it serves as a tool to elucidate the role of group III mGluRs in neuronal survival and excitability regulation
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.